Insider trading

Period: 12 months Stock: AORT Type of trade: Sold × Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

41 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

41 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

41 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

41 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
41 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
41 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

41 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
10 Sep 2026
GREEN ANDREW M SVP, Regulatory and Quality
Sold at will
$286.66K 11,480 at 24.97
22.2%
Not planned
2 Sep 2026
GREEN ANDREW M SVP, Regulatory and Quality
Sold at will
$177.50K 6,510 at 27.27
10.9%
Not planned
19 Aug 2026
Mackin James P President & CEO
Sold at will
$2.03M 70,000 at 28.96
7.4%
Not planned
11 Jun 2026
GREEN ANDREW M SVP, Regulatory and Quality
Sold on a plan 2×
$910.74K 44,001 at 20.70
42.2%
Planned (10b5-1)
4 Mar 2026
Holloway Jean F SVP, General Counsel
Sold at will
$340.56K 8,962 at 38.00
4.6%
Not planned
3 Mar 2026
Mackin James P President & CEO
Sold at will
$675.69K 17,887 at 37.78
1.9%
Not planned
3 Mar 2026
Berry Lance A EVP, COO, CFO & Treasurer
Sold at will
$238.59K 6,316 at 37.78
2.9%
Not planned
3 Mar 2026
Davis John E Chief Commercial Officer
Sold at will
$172.75K 4,573 at 37.78
1.9%
Not planned
3 Mar 2026
Holloway Jean F SVP, General Counsel
Sold at will
$145.17K 3,843 at 37.78
1.9%
Not planned
2 Mar 2026
Mackin James P President & CEO
Sold at will
$566.99K 14,911 at 38.02
1.7%
Not planned
2 Mar 2026
Berry Lance A EVP, COO, CFO & Treasurer
Sold at will
$196.89K 5,178 at 38.02
2.9%
Not planned
2 Mar 2026
Davis John E Chief Commercial Officer
Sold at will
$105.86K 2,784 at 38.02
1.3%
Not planned
24 Feb 2026
Mackin James P President & CEO
Sold at will
$497.42K 13,936 at 35.69
1.8%
Not planned
24 Feb 2026
Berry Lance A EVP, COO, CFO & Treasurer
Sold at will
$160.08K 4,485 at 35.69
3.0%
Not planned
23 Feb 2026
Mackin James P President & CEO
Sold at will
$787.92K 20,962 at 37.59
2.6%
Not planned
23 Feb 2026
Berry Lance A EVP, COO, CFO & Treasurer
Sold at will
$187.23K 4,981 at 37.59
3.2%
Not planned
23 Feb 2026
Davis John E Chief Commercial Officer
Sold at will
$141.82K 3,773 at 37.59
1.9%
Not planned
23 Feb 2026
Holloway Jean F SVP, General Counsel
Sold at will
$115.73K 3,079 at 37.59
2.0%
Not planned
15 Dec 2025
Davis John E Chief Commercial Officer
Sold at will
$225.55K 5,000 at 45.11
2.5%
Not planned
8 Dec 2025
Horton Amy VP, Chief Accounting Officer
Sold at will
$203.08K 4,572 at 44.42
3.4%
Not planned
3 Dec 2025
Mackin James P President & CEO
Sold on a plan
$1.41M 30,921 at 45.46
3.7%
Planned (10b5-1)
3 Dec 2025
Holloway Jean F SVP, General Counsel
Sold at will 2×
$331.37K 7,315 at 45.30
4.5%
Not planned
2 Dec 2025
Mackin James P President & CEO
Sold on a plan
$1.41M 30,921 at 45.56
3.7%
Planned (10b5-1)
21 Nov 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will 4×
$2.13M 47,376 at 45.04
51.4%
Sold half or more
20 Nov 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will 3×
$674.83K 15,276 at 44.18
25.4%
Not planned
18 Nov 2025
Hoff Elizabeth A Director
Sold at will
$189.41K 4,200 at 45.10
13.4%
Not planned
17 Nov 2025
Davis John E Chief Commercial Officer
Sold on a plan
$288.82K 6,394 at 45.17
3.1%
Planned (10b5-1)
17 Nov 2025
Holloway Jean F SVP, General Counsel
Sold on a plan
$288.82K 6,394 at 45.17
3.8%
Planned (10b5-1)
17 Nov 2025
Horton Amy VP, Chief Accounting Officer
Sold at will
$274.38K 6,000 at 45.73
4.2%
Not planned
14 Nov 2025
Holloway Jean F SVP, General Counsel
Sold on a plan
$287.69K 6,393 at 45.00
3.8%
Planned (10b5-1)
14 Nov 2025
Davis John E Chief Commercial Officer
Sold on a plan
$285.58K 6,393 at 44.67
3.1%
Planned (10b5-1)
13 Nov 2025
Mackin James P President & CEO
Sold at will
$1.57M 34,210 at 45.86
4.1%
Not planned
13 Nov 2025
Davis John E Chief Commercial Officer
Sold at will
$300.97K 6,563 at 45.86
3.2%
Not planned
13 Nov 2025
Holloway Jean F SVP, General Counsel
Sold at will
$264.19K 5,761 at 45.86
3.4%
Not planned
13 Nov 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will
$228.97K 4,993 at 45.86
8.1%
Not planned
13 Nov 2025
Horton Amy VP, Chief Accounting Officer
Sold at will
$159.68K 3,482 at 45.86
2.4%
Not planned
11 Nov 2025
Holloway Jean F SVP, General Counsel
Sold at will
$461.80K 10,000 at 46.18
5.6%
Not planned
10 Nov 2025
Mackin James P President & CEO
Sold at will
$784.40K 17,580 at 44.62
2.1%
Not planned
10 Nov 2025
Davis John E Chief Commercial Officer
Sold at will
$150.50K 3,373 at 44.62
1.6%
Not planned
10 Nov 2025
Holloway Jean F SVP, General Counsel
Sold at will
$132.07K 2,960 at 44.62
1.7%
Not planned
10 Nov 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will
$114.49K 2,566 at 44.62
4.0%
Not planned
Showing 1–41 of 41.